Am. J. Respir. Crit. Care Med., Volume 164, Number 1, July 2001, 155-161

Clara Cell Secretory Protein Oxidation and Expression in Premature Infants Who Develop Bronchopulmonary Dysplasia

PATRICIA L. RAMSAY, FRANCESCO J. DeMAYO, SUZANNE E. HEGEMIER, MARY E. WEARDEN, CHARLES V. SMITH, and STEPHEN E. WELTY

Departments of Pediatrics, Molecular and Cellular Biology, Baylor College of Medicine, Houston Texas; and Department of Pediatrics, The Ohio State University, Columbus Ohio

Bronchopulmonary dysplasia (BPD) is a chronic lung disease that affects prematurely born infants and appears to evolve in part from early inflammatory responses in the lung. The inflammatory responses have been associated with protein and lipid oxidation in tracheal aspirate fluids. The present study was designed to test the hypothesis that in the first week of life specific oxidations and/ or altered expressions of proteins would be observed in tracheal aspirate fluids in infants who would subsequently develop BPD. We obtained tracheal aspirate fluids on Days of life 1, 3, and 6 from infants born at  29 wk gestation, incubated the fluids with 2,4-dinitrophenylhyrazine (DNPH), separated the proteins electrophoretically, and assessed DNPH reactivity by immunonblots. DNPH reactivity of a protein that was identified as Clara cell secretory protein (CCSP) was observed more consistently in tracheal aspirate fluids from infants who later developed BPD than from infants who did not develop BPD. Tracheal aspirate fluid levels of immunoreactive CCSP were also lower on Day of life 1 in infants who developed BPD than in those who did not develop BPD. Increased CCSP oxidation and decreased immunoreactive CCSP expression in infants who subsequently developed BPD suggest that Clara cell function and CCSP expression may be critical for normal bronchoalveolar fluid homeostasis and that maintaining CCSP expression and function may be useful goals for targeted therapies for inhibition of the development of BPD.

This article has been cited by other articles:

				A. Bhandari and V. Bhandari Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia Pediatrics, June 1, 2009; 123(6): 1562 - 1573. [Abstract] [Full Text] [PDF]

				C L Bose, C E L Dammann, and M M Laughon Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2008; 93(6): F455 - F461. [Abstract] [Full Text] [PDF]

				R. Fernandez-Valdivia, Y. Zhang, S. Pai, M. L. Metzker, and A. Schumacher l7Rn6 Encodes a Novel Protein Required for Clara Cell Function in Mouse Lung Development Genetics, January 1, 2006; 172(1): 389 - 399. [Abstract] [Full Text] [PDF]

				B. N. Shashikant, T. L. Miller, R. W. Welch, A. L. Pilon, T. H. Shaffer, and M. R. Wolfson Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profiles J Appl Physiol, December 1, 2005; 99(6): 2204 - 2211. [Abstract] [Full Text] [PDF]

				S. D. Reynolds, P. R. Reynolds, G. S. Pryhuber, J. D. Finder, and B. R. Stripp Secretoglobins SCGB3A1 and SCGB3A2 Define Secretory Cell Subsets in Mouse and Human Airways Am. J. Respir. Crit. Care Med., December 1, 2002; 166(11): 1498 - 1509. [Abstract] [Full Text] [PDF]

				S. Kim, J. J. Shim, P.-R. Burgel, I. F. Ueki, T. Dao-Pick, D. C.-W. Tam, and J. A. Nadel IL-13-induced Clara cell secretory protein expression in airway epithelium: role of EGFR signaling pathway Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L67 - L75. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630. [Full Text] [PDF]